MedPath

苏州长征-欣凯制药有限公司

Ownership
-
Established
2000-04-27
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

10

NMPA:10

Drug Approvals

Hydroxychloroquine Sulfate Tablets

Product Name
硫酸羟氯喹片
Approval Number
国药准字H20243758
Approval Date
May 21, 2024
NMPA

Hydroxychloroquine Sulfate

Product Name
硫酸羟氯喹
Approval Number
国药准字H20083189
Approval Date
Jul 19, 2022
NMPA

Leflunomide Tablets

Product Name
爱若华
Approval Number
国药准字H20050129
Approval Date
Jun 5, 2020
NMPA

Thalidomide Capsules

Product Name
沙利度胺胶囊
Approval Number
国药准字H20100186
Approval Date
Jun 5, 2020
NMPA

Leflunomide Tablets

Product Name
爱若华
Approval Number
国药准字H20000550
Approval Date
Jun 5, 2020
NMPA

Leflunomide Tablets

Product Name
爱若华
Approval Number
国药准字H20060034
Approval Date
Jun 5, 2020
NMPA

Leflunomide

Product Name
来氟米特
Approval Number
国药准字H20053117
Approval Date
Jun 5, 2020
NMPA

Glucosamine Indomethacin Entric-coated Tablets

Product Name
氨糖美辛肠溶片
Approval Number
国药准字H20053458
Approval Date
Jun 29, 2015
NMPA

归脾胶囊

Approval Number
国药准字Z20040147
Approval Date
Sep 30, 2010
NMPA

双黄连口服液

Approval Number
国药准字Z32021020
Approval Date
Sep 30, 2010
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.